Predictors of biochemical and structural response to medical therapy in patients with active acromegaly following surgery: a real-world perspective
Abstract Background Somatostatin receptor analogs (SRAs) and dopamine agonists (DAs) are the main medical treatments for patients with acromegaly who fail to achieve remission after surgery. We aimed to explore the potential role of select clinical, biochemical, and radiological factors in predictin...
Saved in:
Main Authors: | Maryam Rafieemanesh, Manizhe Ataee Kachuee, Ali Zare Mehrjardi, Alireza Khajavi, Mohammad Ghorbani, Mohammad Reza Mohajeri-Tehrani, Nahid Hashemi-Madani, Mohammad E. Khamseh |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | BMC Endocrine Disorders |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12902-025-01856-w |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and predictors of response to somatostatin analogues in patients with ectopic ACTH syndrome
by: Olga O. Golounina, et al.
Published: (2024-12-01) -
Acromegaly: Is earlier diagnosis possible? Exploration of a screening algorithm to select high-risk patients
by: Tessa N.A. Slagboom, et al.
Published: (2025-03-01) -
Differential diagnosis of rheumatic manifestations of acromegaly. Case report
by: Margarita A. Perepelova, et al.
Published: (2024-12-01) -
Association of Epicardial Adipose Tissue Thickness with Cardiovascular Risk in Acromegaly
by: Bulent CAN, et al.
Published: (2022-06-01) -
The effect of acromegaly on thyroid disease
by: Caiyan Mo, et al.
Published: (2023-11-01)